Insider Cluster (2 insiders) ·Filed May 7, 2026

LMAT

LEMAITRE VASCULAR INC
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $994K total
Actionable Insight • Neutral

Insider sales are routine and negligible relative to market cap. The strong Q1 earnings and raised guidance are the dominant signal. Monitor for any follow-on insider selling in the next 30 days; if sales accelerate beyond 0.1% of market cap, reassess.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
LMAT ▼ -3.98% at T+60d
NEUTRAL call ✗ call lost -3.98% · α vs SPY -7.82% · entry $107.91 → $103.61
Entry anchored
May 6, 03:59 PM ET
via exchange tick
T+1d
+0.03%
call +0.03% · α -0.80%
$107.94
settled 5mo ago
T+5d
-9.03%
call -9.03% · α -10.53%
$98.17
settled 5mo ago
T+20d
-15.08%
call -15.08% · α -18.21%
$91.64
settled 4mo ago
T+60d
-3.98%
call -3.98% · α -7.82%
$103.61
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Two directors at LeMaitre Vascular sold a combined $994K in open-market sales on May 7, 2026, following the company's strong Q1 2026 earnings beat and raised guidance. The sales are modest relative to the $2.5B market cap (0.04%) and are likely routine portfolio rebalancing after a period of strong stock performance, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$994.0K
Insiders
2

Key Facts

  • Two directors sold a total of $994K in open-market sales on May 7, 2026.
  • Sales represent 0.04% of LMAT's $2.5B market cap — trivial in size.
  • Q1 2026 EPS of $0.68 beat consensus by 3%, revenue of $66.6M was in line.
  • Full-year 2026 guidance raised: operating income midpoint to $79.8M, EPS to $3.00.
  • Both sales were accompanied by derivative exercises at much lower strike prices, indicating the sales were likely to cover tax obligations or lock in gains from options.

Financial Impact

Total insider sales of $994K, or 0.04% of market cap — immaterial.

Risk Factors

  • Insider sales could accelerate if the stock continues to rally, creating a perception of top-picking.
  • No material risk identified from this cluster alone.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
69% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LMAT-1778533892241
11 reports for LMAT
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +17.70%Jul 14, 2026
Filters
Rows
Reports for LMAT — sortable, filterable
TypeNow
Aug 27, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$80.45 $82.34▲ +2.35%▲ +2.09%$78.78 (−2.08%)
Jul 14, 2026
11w ago
Press Release
BEARISH ★ 7/10
$99.79 $82.13▲ +17.70%▲ +20.04%$78.78 (+21.06%)
May 7, 2026
21w ago
Insider Cluster
BEARISH ★ 4/10
$107.91 $91.64▲ +15.08%▲ +18.21%$78.78 (+27.00%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.78 (−27.00%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.78 (−27.00%)
May 5, 2026
21w ago
8-K
BULLISH ★ 7/10
$110.22 $91.64▼ −16.86%▼ −19.64%$78.78 (−28.53%)
Apr 14, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.78 (−32.89%)
Apr 14, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.78 (−32.89%)
Mar 11, 2026
29w ago
Insider Cluster
NEUTRAL ★ 3/10
$108.09 $112.71▲ +4.27%▲ +3.75%$78.78 (−27.12%)
Feb 26, 2026
31w ago
Insider Cluster
BEARISH ★ 7/10
$113.43 $110.33▲ +2.73%▼ −3.67%$78.78 (+30.55%)
Showing 10 of 11

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 11, 2026